IKA vs Injective — how do they compare? IKA trades at Rp45.92 (market cap Rp143,87M, Rp14,72M 24h volume), while Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume). The key difference: Injective is far larger — about 63807.6× IKA's market cap, and IKA's circulating supply is 3B IKA versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold IKA for 2 Days and Injective for 36 Days on average.
| IKA | INJ | |
|---|---|---|
Market Cap | Rp143,87M | Rp9,18T |
Volume (24h) | Rp14,72M | Rp1,72T |
Circulating Supply | 3B IKA | 100M INJ |
Typical Hold Time | 2 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
IKA is trading at Rp46.25 with a market cap of Rp139.18M, showing a bullish technical signal supported by moving averages. Current price hovers near the pivot point of Rp47, with immediate support at Rp45 and resistance at Rp49. The token exhibits neutral oscillators but strong trend momentum indicated by ADX readings above 60. No major protocol updates or ecosystem developments have been reported recently, keeping fundamental drivers limited.
Overall outlook is cautiously optimistic due to bullish technical alignment, but investors should note the low market cap and limited liquidity as primary risks. Key opportunities include potential breakout above Rp49, while major risks involve high volatility and minimal exchange depth. The 2-day average hold time suggests short-term trader dominance, increasing price sensitivity to market sentiment shifts.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ika is a decentralized network enabling secure, native cross-chain interoperability through advanced cryptography. It allows smart contracts to manage assets across multiple blockchains without relying on bridges or wrapped tokens. Using 2PC-MPC cryptography, Ika provides zero-trust asset control across chains like Bitcoin and Ethereum. Its dWallet primitive enables programmable, consent-based signing, and it is built on Sui for high-speed, scalable transactions.
Read more on IKA →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →